Geron to Announce Third Quarter Financial Results on November 6, 2019
October 31 2019 - 8:00AM
Geron Corporation (Nasdaq: GERN) today announced that it will
release its third quarter 2019 financial results after the market
closes on Wednesday, November 6, 2019 via press release, which will
be available on the Company’s website at www.geron.com/investors.
Geron will host a conference call on Thursday, November 7 at 8:00
a.m. ET to discuss the financial results as well as recent events.
Participants may access the conference call live via telephone
by dialing domestically +1 (866) 393-4306 or internationally +1
(734) 385-2616. The passcode is 2929819. Participants are advised
to dial in at least 10 minutes prior to minimize any delay in
joining the call. A live, listen-only webcast will also be
available on the Company’s website at
www.geron.com/investors/events. If you are unable to listen to the
live call, an archived webcast will be available on the Company’s
website for 30 days.
About Geron
Geron is a late-stage clinical biopharmaceutical company focused
on the development and potential commercialization of a
first-in-class telomerase inhibitor, imetelstat, in hematologic
myeloid malignancies. For more information about Geron, visit
www.geron.com.
CONTACT:
Suzanne MessereInvestor and Media Relationsinvestor@geron.com
media@geron.com
CG Capital877-889-1972
Geron (NASDAQ:GERN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Geron (NASDAQ:GERN)
Historical Stock Chart
From Sep 2023 to Sep 2024